Evaluating Psoriasis Severity Using the Neutrophil‐to‐Lymphocyte Ratio and Platelet‐to‐Lymphocyte Ratio: A Systematic Review and Meta‐Analysis
Experimental Dermatology · 2026-01 · 35 (1)
DOI: 10.1111/exd.70214 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Experimental Dermatology, online erschienen am 22.01.2026. Verfasst von Yi-Hsuan Shen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Psoriasis, Neutrophils, Lymphocytes, Blood Platelets. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: Wan Fang Hospital.
Abstract (Originalsprache)
Currently, there is a lack of reliable laboratory tests for monitoring the severity of psoriasis and evaluating treatment efficacy. The neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio (PLR) are novel parameters of systemic inflammation. This study aimed to evaluate the association between NLR, PLR and psoriasis. Databases were systematically searched for studies up to May 2025. Publications meeting any of the following criteria were eligible: (1) comparison of NLR and PLR between psoriasis patients and healthy controls, (2) correlation coefficient of NLR and PLR and Psoriasis Area Severity Index (PASI) score, and (3) NLR and PLR before and after 3–4 months of biologic therapies. The pooled results showed that the NLR and PLR were significantly higher in patients with psoriasis than in controls (standardised mean difference [SMD] = 0.645, 95% confidence interval [CI] 0.514–0.775; SMD = 0.467, 95% CI 0.304–0.630). Both NLR and PLR were significantly correlated with the PASI score ( r = 0.214, 95% CI 0.178–0.250; r = 0.161, 95% CI 0.114–0.207). The NLR and PLR significantly decreased after receiving tumour necrosis factor‐α blockers, ustekinumab, and interleukin‐23 inhibitors for 3–4 months. The NLR and PLR may serve as convenient tools in monitoring psoriasis treatment and indicators of systemic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
- Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
- Department of Dermatology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
ORCID-Profile: Yi-Hsuan Shen, Pei-Yun Ho
Förderung
- Wan Fang Hospital
Zitieren
APA
Shen, Y. H., Ho, P. Y., & Huang, Y. C. (2026). Evaluating Psoriasis Severity Using the Neutrophil‐to‐Lymphocyte Ratio and Platelet‐to‐Lymphocyte Ratio: A Systematic Review and Meta‐Analysis. Experimental Dermatology, 35(1). https://doi.org/10.1111/exd.70214
Vancouver
Shen YH, Ho PY, Huang YC. Evaluating Psoriasis Severity Using the Neutrophil‐to‐Lymphocyte Ratio and Platelet‐to‐Lymphocyte Ratio: A Systematic Review and Meta‐Analysis. Experimental Dermatology. 2026;35(1). doi:10.1111/exd.70214
BibTeX
@article{Shen2026,
author = {Shen, Yi-Hsuan and Ho, Pei-Yun and Huang, Yu-Chen},
title = {Evaluating Psoriasis Severity Using the Neutrophil‐to‐Lymphocyte Ratio and Platelet‐to‐Lymphocyte Ratio: A Systematic Review and Meta‐Analysis},
journal = {Experimental Dermatology},
year = {2026},
volume = {35},
number = {1},
doi = {10.1111/exd.70214}
}
EUVIMED